The FDA has granted Breakthrough Device Designation to Orchestra BioMed's Atrioventricular Interval Modulation (AVIM) therapy, aimed at treating patients with uncontrolled hypertension who are at ...

Orchestra BioMed’s hypertension treatment is the latest medical device to earn the FDA’s breakthrough designation. The device is an atrio-ventricular interval modulation therapy, meaning it uses a ...

Orchestra BioMed (OBIO) announced a late-breaking oral presentation of data on the benefits of atrioventricular interval modulation therapy on patients with diastolic dysfunction at the Technology and ...

Atrioventricular interval modulation (AVIM) therapy for hypertension may help address this common comorbidity among patients with pacemakers. For patients with pacemakers, hypertension is a common ...

Orchestra BioMed has announced that the FDA has granted Breakthrough Device Designation for its atrioventricular interval modulation (AVIM) therapy, aimed at treating over 7.7 million U.S. patients ...

Breakthrough Device Designation (“BDD”) applies to an estimated U.S. population of over 7.7 million patients with uncontrolled hypertension and increased cardiovascular risk BDD also encompasses ...

Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by ...